Protagonist Therapeutics, Inc. <PTGX.O>: JP Morgan raises target price to $149 from $113
PTGX•Related News
Yum China Q2 FY26 net income rises 14% to $244 million; revenue increases 13% to $3.14 billion
YUMC•
Rubrik Inc: BTIG raises target price to $109 from $91
RBRK•
Amundi Physical Metals issues 228,000 new Amundi Physical Gold ETC securities tranche
GLD•
Celsius Holdings Inc <CELH.O>: Stephens cuts target price to $50 from $65
CELH•
Emergent BioSolutions Inc. <EBS.N>: H.C. Wainwright cuts target price to $10 from $12
EBS•